Financials data is unavailable for this security.
View more
Year on year OrganoClick AB grew revenues 26.79% from 115.05m to 145.87m. Additionally the company has reduced the cost of goods sold, selling, general and administrative expenses and debt expenses (all as percentages of sales). These changes narrowed profitability losses from -44.40m to -15.77m.
Gross margin | 20.60% |
---|---|
Net profit margin | -11.60% |
Operating margin | -6.82% |
Return on assets | -10.05% |
---|---|
Return on equity | -39.47% |
Return on investment | -28.07% |
More ▼
Cash flow in SEKView more
In 2023, cash reserves at OrganoClick AB fell by 4.47m. Cash Flow from Financing totalled 3.60m or 2.47% of revenues. In addition the company generated 533.00k in cash from operations while cash used for investing totalled 8.61m.
Cash flow per share | 0.0018 |
---|---|
Price/Cash flow per share | 1,683.62 |
Book value per share | 0.3757 |
---|---|
Tangible book value per share | -0.0668 |
More ▼
Balance sheet in SEKView more
Current ratio | 0.7331 |
---|---|
Quick ratio | 0.3432 |
Total debt/total equity | 1.29 |
---|---|
Total debt/total capital | 0.5070 |
More ▼